In December, powerhouse drugmaker Pfizer completed a roughly $43 billion acquisition of Seagen. The transaction proved to be far and away the largest M&A deal by volume in global healthcare last year, according to data from deal-tracking firm Dealogic. It was more than double the value of the next-largest deal, a Japanese healthcare merger that clocked in at $22 billion.